$BRBS

Gavant Judy Carol sold (to issuer) 7,474 shares of BRBS

Gavant Judy Carol (EVP & Chief Financial Officer) sold (to issuer) 7,474 shares of BLUE RIDGE BANKSHARES, INC. (BRBS) on 2026-07-01.

Original reporting
SEC EDGAR · Gavant Judy Carol
Published Jul 7, 2026, 9:29 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 7, 2026, 9:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BRBS
Neutral
medium confidence
Mentioned
$BRBS
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BRBSNeutralLow
01

Why it matters

This disclosure updates insider activity records but does not provide new operating, financial, or regulatory information that would typically drive repricing.

02

Market read

Traders may monitor for clustering of insider sales/buys, but this specific filing lacks disclosed price/value and appears routine.

03

What to watch

No 10b5-1 plan is stated, but the transaction code indicates sale to issuer; traders should check for other contemporaneous insider trades and any concurrent buyback activity.

Relevance 4/10Novelty 4/10Timing: filed 2026-07-07 after-hours; reflects 2026-07-01 insider sale

Background

The article is a SEC Form 4 insider transaction for Blue Ridge Bankshares, Inc. (BRBS) by its EVP & CFO.

Company-level read

Ticker impact

$BRBSNeutralMedium confidence
Context

Blue Ridge Bankshares CFO sold 7,474 shares to the issuer under Form 4, with price undisclosed and holdings at 569,898 shares.

Expected impact

Low likelihood of a sustained price move based solely on this Form 4.

Evidence & confidence

The filing is a primary insider transaction, but the article provides no sale price/value and no 10b5-1 plan, reducing interpretability and materiality versus earnings/guidance or corporate actions.

Market effects

Minimal—single-bank insider transaction without disclosed financial impact is unlikely to reset sector expectations.

Minimal—no regional credit or regulatory catalyst described.

None—domestic insider Form 4 with no broader linkage.

Counterpoint

The sale could be administrative (e.g., issuer buyback participation) rather than a bearish view; without price/value, it may not reflect fundamentals.

Key entities

  • BLUE RIDGE BANKSHARES, INC.

    Company whose EVP & CFO filed the Form 4 insider sale to issuer (code D).

  • Gavant Judy Carol

    EVP & Chief Financial Officer who sold 7,474 shares to the issuer on 2026-07-01.

Related articles

$BRBSMed

Blue Ridge Bankshares, Inc. Announces 2026 Second Quarter Results

Blue Ridge Bankshares (NYSE American: BRBS) reported a Q2 2026 net loss of $0.2 million, or $0.00 per diluted share, versus net income of $0.8 million in Q1 2026. The quarter included a $2.1 million after-tax credit-loss provision and $0.3 million after-tax severance. Loans grew at a 4% annualized rate; NIM was 2.91%.

$BRBSMed

BLUE RIDGE BANKSHARES, INC. (BRBS): Results of Operations and Financial Condition

BLUE RIDGE BANKSHARES, INC. (BRBS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 brbs-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Blue Ridge Bankshares, Inc. Announces 2026 Second Quarter Results Loan Growth Returns, Improved Deposit Mix, and Continued Reduction in Operating Expenses RICHMOND, VA, July 28, 2026 /PRNewswire/ -- Blue Ridge Bankshares, Inc